ChemicalBook Chinese Germany Japanese Korean

TargetMol中国（陶术生物） Company Information
Company Name:    TargetMol Chemicals Inc.
Tel:    -
Email:    marketing@targetmol.cn
Nationality:    China
WebSite:    https://www.targetmol.cn/
Product List:    29243
71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175
Product List
P 218 1142407-60-0
ENT-C225 2919962-53-9
PU.1-IN-1 873588-27-3
STC314 186295-19-2
TJ08 2924274-19-9
Larotinib 1438072-11-7
AXL-IN-13 2376928-82-2
SMN-C2 1446311-56-3
ccc_R08 2919019-72-8
SRI-42127 2727872-68-4
DC-BPi-03 2758411-46-8
SOS1-IN-15 2793404-47-2
PRMT6-IN-3 2890765-10-1
hCAII-IN-9 2878477-18-8
CpG ODN 10101 1234402-77-7
USP28-IN-3 2931509-14-5
STING agonist-30 2951078-67-2
DATPT 2891582-75-3
RSS0680 2769753-48-0
TGFβ1-IN-2 2700263-58-5
[Sar1, Ile8]-Angiotensin II 3TFA
Endo-1,3-β-glucanase 9025-37-0
MitoSOX Red 1003197-00-9
Senktide acetate
Angiotensin 1/2 (1-9) TFA
GW297361 388627-21-2
Cibisatamab 1855925-27-7
Brentuximab 2088770-90-3
Zilovertamab 1643432-38-5
Inotuzumab 1660159-36-3
GSNKGAIIGLM(131602-53-4(free base))
Sonepcizumab 1031360-18-5
Ordesekimab 879293-15-9
Theralizumab 906068-56-2
Clivatuzumab 1622075-09-5
DSPE-NHS 1383932-86-2
TV 3279 209394-29-6
HDAC-IN-57 2716217-79-5
PLH2058 2525206-41-9
MyD88-IN-1 2911609-80-6
lorvotuzumab 339306-30-8
Bivatuzumab 214559-60-1
Enfortumab 1448664-46-7
TNF-α-IN-9 2054199-25-4
HA5 2378406-17-6
FC-116 2417298-29-2
PLH1215 1332084-64-6
AP-C2 682793-07-3
Cbl-b-IN-5 2368835-59-8
KSK67 2566715-93-1
Anti-inflammatory agent 51 2911610-03-0
BCPA 547731-67-9
Z16078526 852222-94-7
MMP-9-IN-6 2241964-36-1
VU534 923509-20-0
1H-Indole, 3,3'-(2-thienylmethylene)bis[2-methyl- 138801-72-6
BPDA2 2907659-86-1
NP10679 2914889-88-4
CZL55 667408-87-9
CLK8 898920-65-5
GSK3-IN-3 331963-27-0
RSH-7 2764609-97-2
AUTAC1 2241669-09-8
Glembatumumab vedotin 1182215-65-1
Akt3 degrader 1 2836342-69-7
GRGDSPK acetate 144027-77-0
TGFβ1-IN-3 2883813-58-7
Nurr1 agonist 2 742058-34-0
P-gb-IN-1 2632874-49-6
KM02894 116850-74-9
17β-HSD10-IN-1 2316765-78-1
A2B receptor antagonist 2 hydrochloride 724-70-9
SARS-CoV-2-IN-39 2882823-03-0
BCAT-IN-4 406190-85-0
Antiviral agent 34 945152-88-5
LSD1-IN-27 2904571-94-2
CCG-13514 423741-32-6
JHU 75528 947696-17-5
DJ4 1681020-24-5
Topoisomerase II inhibitor 14 305343-00-4
Tubulin polymerization-IN-43 2773345-90-5
LW3 2803367-68-0
MoTPS1-IN-1 2991072-02-5
PI3Kδ-IN-16 2766437-35-6
(1R,5S,6r)-N-(2-methyl-1-((3-methylpyridin-2-yl)oxy)propan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide L(+)-Tartaric acid 2919211-45-1
Tubulin polymerization-IN-55 2942396-29-2
RN-1665 1803003-65-7
XPW1 2700286-66-2
QST4 2991427-35-9
ALK-IN-26 2447607-85-2
Ipamorelin 2 Pivalic acid
Enpp-1-IN-16 2289739-47-3
MC4033 28532-21-0
Aprocitentan 1103522-45-7
CpCDPK1/TgCDPK1-IN-1 1092788-23-2
IRG1-IN-1 2407652-42-8
MY-1076 3008262-76-5
AST 7062601 675197-89-4
PAC1R antagonist 1 2305204-24-2
LFHP-1c 2102347-47-5
71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175
Copyright 2007©  ChemicalBook. All rights reserved.